AC Immune's Janssen-partnered Alzheimer's vaccine spurs tau-attacking antibodies in early-stage trial

AC Immune and partner Janssen have found an early-stage Alzheimer’s disease vaccine spurs induction of antibodies that attack a type of tau, which is believed to tangle up in the brain and contribute to the devastating neurological disorder.